Palantir Technologies
PLTR
$172.40
+2.12%
Palantir Technologies is an artificial intelligence and data-analytics software company whose Foundry and Gotham platforms help commercial and government clients integrate disparate data into decision-making workflows, operating within the enterprise software and data infrastructure industry. The company occupies a distinctive position as a high-touch, forward-deployed engineering platform serving only Western-allied nations, positioning it as a sovereign-AI and defense-adjacent contractor rather than a conventional SaaS vendor. The current investor narrative is dominated by explosive U.S. commercial acceleration — U.S. revenue reportedly surged 119% with commercial revenue surpassing government revenue for the first time — which bulls frame as proof of durable AI-driven demand even as other AI names falter. That enthusiasm is being actively contested by bears focused on extreme valuation multiples, flat remaining performance obligations, and a sharp slowdown in total contract value growth flagged in the Q3 report, making the stock a battleground between growth conviction and multiple-compression risk.…
PLTR
Palantir Technologies
$172.40
Related headlines
Investment Opinion: Should I buy PLTR Today?
Rating: Hold with a bullish bias. Palantir is a genuinely elite business — 95.87% revenue growth, 48.76% net margin, $4.054 billion of TTM free cash flow, and a fortress balance sheet with debt-to-equity of 0.031 — but at $160.38 the stock trades at 94.1x sales and 257.6x trailing earnings, so the analyst consensus of "buy" (22 Buy, 9 Hold, 2 Sell; mean 1.85) and the $222.25 average target implying +38.6% upside must be weighed against a $80 low target that implies roughly -50%. The core thesis is that Palantir's commercial inflection — commercial revenue of $1.168 billion now exceeding government's $1.146 billion, with U.S. revenue up 119% — is real and durable, but the current price already capitalizes years of flawless execution, so the risk/reward is balanced rather than compelling at this entry point.
Supporting evidence for the constructive stance is concrete: revenue accelerated sequentially from $1.633 billion in Q1 to $1.935 billion in Q2 to $2.313 billion in Q3 (roughly 42% across three quarters), operating margin expanded from 40.90% in Q4 2025 to 46.89% in Q3 2026, gross margin holds at 83.43%, and TTM free cash flow of $4.054 billion against $3.653 billion of cash means the business is entirely self-funding. The PEG ratio of 1.13 is the one valuation metric that looks reasonable, and it rests on the consensus forward EPS of $14.38 versus trailing EPS of $0.0039 — a forecast that requires earnings to roughly quadruple. Against a software sector that typically commands 10–20x sales, Palantir's 94.1x PS is a 5–9x premium that only a 95.87% grower with 48.76% net margins can even attempt to justify.
The risks that would invalidate this thesis are specific and measurable. First, flat remaining performance obligations and a sharp slowdown in total contract value growth in Q3 are the leading indicators that precede revenue deceleration, and the stock fell on those metrics despite the revenue beat. Second, the momentum unwind is already visible — -17.38% over one month versus the S&P 500's -4.99%, a relative strength of -12.39, and a -8.38% one-year change despite a +16.39% six-month gain. Third, stock-based compensation of $318.9 million (about 13.8% of revenue) dilutes shareholders against 2.574 billion diluted shares. This Hold would upgrade to Buy on a pullback toward the $106–$120 zone (near the 52-week low of $106.37) or on evidence that RPO and contract value growth have re-accelerated; it would downgrade to Sell if Q4 revenue growth decelerates materially below the 95.87% pace while the multiple stays above 60x sales. Verdict: fairly valued to modestly overvalued relative to history and peers — not a valuation call to chase, but not a business to abandon.
Sign up to view all
PLTR 12-Month Price Forecast
Palantir presents a rare combination of hyper-growth and elite profitability — 95.87% revenue growth, 48.76% net margin, $4.054 billion of TTM free cash flow, and negligible debt — that justifies a premium multiple but not necessarily the current 94.1x sales and 257.6x trailing PE. The bull case rests on harder, backward-looking evidence, while the bear case rests on forward-looking leading indicators (flat RPO, slowing contract value growth) and a momentum unwind that has already produced a -17.38% one-month decline and -12.39 relative strength versus the S&P 500. The 3.4x spread between the $80 low and $273 high analyst targets, combined with a 1.61 beta and -48.22% max drawdown, argues for disciplined position sizing rather than concentrated conviction. I would upgrade to bullish if Q4 shows RPO and contract value growth re-accelerating while the multiple compresses toward 60x sales, and downgrade to bearish if revenue growth decelerates below 50% or the stock breaks decisively below the $155 recent low, opening a test of the $106.37 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Palantir Technologies's 12-month outlook, with a consensus price target around $222.25 and implied upside of +28.9% versus the current price.
Average Target
$222.25
33 analysts
Implied Upside
+28.9%
vs. current price
Analyst Count
33
covering this stock
Price Range
$80 - $273
Analyst target range
Coverage is broad and predominantly constructive, with 28 analysts split 22 Buy, 9 Hold, and 2 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.85. The average target price of $222.25 implies roughly +38.6% upside from the current $160.38, a bullish signal that stands in sharp contrast to the stock's recent -17.38% one-month decline. Recent actions show stability rather than momentum — Barclays, Citigroup, Truist, DA Davidson, Piper Sandler, and Rosenblatt reiterated Buy/Overweight ratings on November 3–4, while Morgan Stanley and Cantor Fitzgerald maintained Equal Weight/Neutral and RBC stayed at Underperform, indicating the bullish consensus is holding but not broadening.
The target range is extremely wide, from a low of $80.00 to a high of $273.00 — a spread of more than 3.4x — which signals unusually high uncertainty and divergent views on the durability of growth. The $273 high target likely assumes continued 90%+ revenue growth, commercial expansion, and sustained premium multiples, while the $80 low target (roughly -50% from current levels) prices in severe multiple compression, decelerating contract value growth, and a return to more normalized software valuations. The wide dispersion, combined with a beta of 1.61 and a -48.22% max drawdown, argues for disciplined position sizing and dollar-cost averaging rather than concentrated conviction, since even the sell-side cannot agree on whether Palantir is a generational AI platform or a dangerously overvalued momentum trade.
Bulls vs Bears: PLTR Investment Factors
The bull case currently rests on harder evidence: 95.87% revenue growth, commercial revenue surpassing government for the first time, 48.76% net margins, $4.054 billion of TTM free cash flow, and a 22-to-2 analyst Buy/Sell split with 38.6% implied upside. The bear case is equally specific but more forward-looking: 94x sales and 258x trailing PE price in years of flawless execution, while flat RPO and slowing total contract value growth are the first credible leading indicators of deceleration. On balance the fundamental evidence favors the bulls, but the valuation and momentum evidence favors the bears — which is why the stock is -17.38% in a month despite a 95.87% growth rate. The single most important tension is whether the flat RPO and slowing contract value growth are a one-quarter air pocket or the leading edge of a deceleration that would compress a 94x sales multiple; that one factor, more than any other, determines whether the $222 average target or the $80 low target is the right anchor.
Bullish
- Revenue growth accelerating at 95.87% YoY: Q3 2026 revenue reached $2.313 billion, up 95.87% year-over-year, with sequential growth from $1.633 billion in Q1 to $1.935 billion in Q2 — roughly 42% sequential expansion across three quarters. This is acceleration, not deceleration, and it is occurring while other AI names falter, which is the single strongest data point in the bull case.
- Commercial revenue overtakes government: Commercial revenue of $1.168 billion now exceeds government revenue of $1.146 billion for the first time, with U.S. revenue reportedly up 119%. This structural broadening beyond Palantir's defense roots reduces concentration risk and validates the commercial AI land-and-expand thesis.
- Elite margins with operating leverage: Q3 gross margin was 83.43%, operating margin 46.89%, and net margin 48.76% on $1.128 billion of net income. Operating margin rose from 40.90% in Q4 2025 to 46.89% in Q3 2026 as revenue scaled far faster than the $845 million of operating expenses, demonstrating genuine software leverage rather than consulting economics.
- Fortress balance sheet, self-funding: Debt-to-equity is just 0.031, the current ratio is 7.11, and TTM free cash flow is $4.054 billion against $3.653 billion of cash. With ROE of 22.0% and ROA of 19.3%, there is essentially no balance-sheet risk and no dependence on external capital.
Bearish
- Valuation at 94x sales, 258x trailing PE: PS ratio is 94.1x, EV/Sales 51.6x, EV/EBITDA 249.5x, and trailing PE 257.6x — roughly a 5–9x premium to a software sector that already commands 10–20x sales. The forward PE of 63.3x requires earnings to roughly quadruple to the $14.38 consensus EPS from trailing EPS of $0.0039, leaving no room for disappointment.
- Flat RPO and slowing contract value growth: The Q3 report showed flat remaining performance obligations and a sharp slowdown in total contract value growth, which are the leading indicators of future revenue. The stock fell after Q3 results specifically on these metrics, suggesting the market is beginning to discount the growth trajectory rather than the backward-looking revenue beat.
- Momentum unwind and idiosyncratic de-rating: The stock is -17.38% over one month versus the S&P 500's -4.99%, producing a relative strength of -12.39 — a clear signal of company-specific de-rating rather than market beta. The 1-year change is -8.38% despite a +16.39% six-month gain, meaning the stock has round-tripped much of its advance and failed near $209 in mid-October.
- Extreme target dispersion signals uncertainty: Analyst targets range from $80 to $273 — a spread of more than 3.4x — with the $80 low implying roughly -50% downside. When the sell-side cannot agree on whether this is a generational platform or an overvalued momentum trade, position sizing risk is elevated, compounded by a beta of 1.61 and a -48.22% max drawdown.
PLTR Technical Analysis
Palantir is in a volatile, range-bound consolidation rather than a clean trend, with the 1-year price change at -8.38% despite a powerful 6-month gain of +16.39%, meaning the stock has round-tripped much of its prior advance. At $160.38, the shares sit at roughly 52% of the 52-week range between a $106.37 low and a $212.94 high — a neutral-to-mid positioning that offers neither the momentum confirmation of new highs nor the deep-value setup of a washed-out base. The stock's -48.22% max drawdown underscores how violently this range has been traversed, and the recent failure near $209 in mid-October reinforces that the upper band is a supply zone.
Short-term momentum has deteriorated sharply and now diverges from the medium-term trend: the 1-month change is -17.38% versus the 3-month change of -6.76%, indicating an accelerating selloff into early November. That -17.38% one-month move badly lags the S&P 500's -4.99%, producing a relative strength reading of -12.39 over one month, a clear signal of idiosyncratic de-rating rather than mere market beta. The divergence between the +16.39% six-month gain and the -17.38% one-month loss is characteristic of a momentum unwind or mean-reversion event, and the sharp drop from $184.11 on October 30 to $154.99 on November 5 — followed by a +3.48% bounce to $160.38 on volume of 24.3 million shares — suggests capitulation-style selling meeting tentative dip-buying.
Key technical levels are well defined: support rests at the $154.99 recent low and, more structurally, the $106.37 52-week low, while resistance sits at the $209–$212.94 October high zone. A decisive break below $155 would likely open a test of the $106 area and confirm a lower-highs downtrend, whereas reclaiming $185–$200 would repair the chart and reassert the medium-term uptrend. With a beta of 1.61, Palantir is roughly 61% more volatile than the market, meaning position sizing must account for amplified drawdowns — the -48.22% max drawdown is a realistic stress-case template, and a short ratio of 2.37 indicates moderate but not extreme short interest that could fuel squeezes on any upside catalyst.
Beta
1.61
1.61x market volatility
Max Drawdown
-48.2%
Largest decline past year
52-Week Range
$106-$213
Price range past year
Annual Return
-9.7%
Cumulative gain past year
| Period | PLTR Return | S&P 500 |
|---|---|---|
| 1m | -17.5% | -2.4% |
| 3m | -3.7% | -2.3% |
| 6m | +28.7% | +2.8% |
| 1y | -9.7% | +11.3% |
| ytd | +2.7% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PLTR Fundamental Analysis
Revenue growth is not merely strong but accelerating at a remarkable clip: Q3 2026 revenue reached $2.313 billion, up 95.87% year-over-year, building on a sequential progression from $1.633 billion in Q1, $1.935 billion in Q2, and $1.406 billion in Q4 2025. The segment mix is now balanced with Commercial at $1.168 billion and Government at $1.146 billion, and the fact that commercial has overtaken government marks a structural broadening of the demand base beyond Palantir's defense roots. This trajectory — roughly 42% sequential growth from Q1 to Q3 — implies the investment case has shifted from government-contract stability to commercial AI land-and-expand, though the flat RPO and slowing total contract value growth noted in the Q3 reaction are the key leading indicators to monitor for deceleration.
Profitability has inflected dramatically and is now best-in-class: Q3 net income was $1.128 billion against $2.313 billion of revenue, a 48.76% net margin, with gross margin at 83.43% and operating margin at 46.89%. The margin expansion is striking — net margin climbed from 43.27% in Q4 2025 to 53.32% in Q1, 54.86% in Q2, and 48.76% in Q3, while operating margin rose from 40.90% to 46.89% over the same span, reflecting operating leverage as revenue scaled far faster than the $845 million of operating expenses. Gross margin has compressed modestly from 86.78% in Q1 to 83.43% in Q3, a trend worth watching as commercial mix grows, but at these levels Palantir's profitability is far above typical enterprise-software norms and supports the premium narrative.
Financial health is exceptional: debt-to-equity is just 0.031, the current ratio is 7.11, and TTM free cash flow is $4.054 billion against Q3 operating cash flow of $1.205 billion, meaning the business funds itself entirely internally. ROE of 22.0% and ROA of 19.3% confirm high capital efficiency, and with $3.653 billion of cash at period end and negligible debt, there is essentially no balance-sheet risk. The one blemish is stock-based compensation of $318.9 million in Q3 — roughly 13.8% of revenue — which dilutes shareholders and is a legitimate governance concern, though free cash flow of $1.197 billion in the quarter comfortably absorbs it.
Quarterly Revenue
$2.3B
2026-09
Revenue YoY Growth
+95.9%
YoY Comparison
Gross Margin
83.4%
Latest Quarter
Free Cash Flow
$4.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PLTR Overvalued?
Because Palantir is solidly profitable (Q3 net income of $1.128 billion), the PE ratio is the appropriate primary metric, and it tells a stark story: the trailing PE is 257.6x while the forward PE is 63.3x. That enormous gap implies the market expects earnings to roughly quadruple, consistent with the analyst consensus EPS estimate of $14.38 versus the current trailing EPS of $0.0039 — a forecast that embeds extraordinary margin and share-count assumptions and leaves little room for disappointment. The PEG ratio of 1.13 is the one metric that looks reasonable, but it depends entirely on that hyper-growth assumption holding.
Relative to software-industry norms, Palantir trades at a breathtaking premium: a PS ratio of 94.1x, EV/Sales of 51.6x, EV/EBITDA of 249.5x, and price-to-book of 57.0x are multiples typically associated with only the most extreme growth stories. Even against a sector that routinely commands 10–20x sales, Palantir's 94x PS represents a roughly 5–9x premium, which can only be justified by its 95.87% revenue growth and 48.76% net margin — genuinely elite metrics, but the price already capitalizes years of flawless execution. The 197.3x price-to-cash-flow ratio further illustrates that investors are paying for a future state, not current cash generation.
Historically, Palantir's own valuation band has been wide but is now near the upper end: PS ratio stood at 61.7x in Q4 2023 and 115.4x in Q3 2024, versus 194.5x in Q3 2026, while PE has ranged from 99.5x to 551x over the past two years and now sits at 257.6x trailing. The stock is therefore not at an all-time valuation extreme — Q3 2026's 194.5x PS is below the 301.6x recorded in Q4 2025 — but it remains far above its 2023–2024 baseline, implying the market is still pricing in highly optimistic expectations and remains vulnerable to multiple compression if growth decelerates.
PE
257.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 66x~290x
vs. Industry Avg
26.1x
Industry PE ~26.1x*
EV/EBITDA
249.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the mismatch between a 94.1x PS and 257.6x trailing PE and any wobble in the growth rate that justifies them. Flat remaining performance obligations and a sharp slowdown in total contract value growth in Q3 are the specific metrics that would precede a revenue deceleration, and because the forward PE of 63.3x requires EPS to roughly quadruple to the $14.38 consensus from trailing EPS of $0.0039, even a modest miss in that trajectory would force a violent re-rating. Stock-based compensation of $318.9 million, about 13.8% of revenue, adds ongoing dilution against 2.574 billion diluted shares, and gross margin has already compressed modestly from 86.78% in Q1 to 83.43% in Q3 as commercial mix grows. The balance sheet itself is not a risk — debt-to-equity of 0.031, current ratio of 7.11, and $3.653 billion of cash — so the financial risk is entirely valuation and growth-durability risk, not solvency risk.
Market and competitive risks are dominated by multiple compression: at 94.1x sales and 51.6x EV/Sales, Palantir trades at roughly a 5–9x premium to a software sector that already commands 10–20x, and its own PS has ranged from 61.7x in Q4 2023 to 301.6x in Q4 2025, so the current 194.5x quarterly reading is below the peak but far above the 2023–2024 baseline. With a beta of 1.61, the stock is roughly 61% more volatile than the market, and the October 16 AI-software valuation reversal showed how quickly sector rotation can hit names like this — the stock fell from $184.11 on October 30 to $154.99 on November 5. Competitive and narrative risk is real too: the "Palantir looks like a consulting company" critique persists, and the forward-deployed engineering model is more labor-intensive than pure SaaS, while the Western-allied-nations-only policy limits the addressable market. Recent coverage explicitly flags governance and valuation risk, with one Wall Street piece naming PLTR among AI stocks that could drop 57–60%.
Worst-case scenario: contract value growth and RPO continue to flatten, Q4 revenue decelerates below the 95.87% pace, and the market reprices the stock toward a more normalized software multiple, dragging it to the $106.37 52-week low — a loss of roughly -33.7% from $160.38. A more severe outcome, consistent with the $80 analyst low target and the -48.22% historical max drawdown, would imply a decline of about -50% from the current price if multiple compression coincides with a growth scare. The realistic downside band is therefore -34% to -50%, and with a short ratio of only 2.37 there is limited squeeze cushion to offset a sustained de-rating.
FAQ
The most severe risk is valuation compression: 94.1x sales and 257.6x trailing PE leave no cushion, and the October 16 AI-software valuation reversal plus the drop from $184.11 on October 30 to $154.99 on November 5 show how fast the multiple can contract. Second is demand-durability risk — Q3 showed flat remaining performance obligations and a sharp slowdown in total contract value growth, the leading indicators that precede revenue deceleration, and the stock fell on those metrics despite a 95.87% revenue beat. Third is dilution and governance: stock-based compensation of $318.9 million is about 13.8% of revenue, and diluted shares of 2.574 billion versus 2.406 billion basic erode per-share economics at a 258x PE. Fourth is macro and sector rotation, amplified by a beta of 1.61 — the stock is roughly 61% more volatile than the market, and its -48.22% max drawdown is a realistic stress template. Ranked by severity: valuation compression first, demand durability second, dilution third, macro rotation fourth.
The scenario framework assigns a 55% probability to the base case of $160–$222.25, in which revenue growth moderates from 95.87% toward 50–70%, gross margin holds above 80%, operating margin stays in the mid-40s, and the multiple compresses modestly while the earnings ramp toward $14.38 offsets it. The bull case carries 20% odds and a $222.25–$273 range, requiring RPO and contract value growth to re-accelerate in Q4 and 90%+ growth to persist into 2027, supported by catalysts like sovereign-AI wins and further upgrades after Goldman Sachs' $230-target Buy initiation. The bear case carries 25% odds and an $80–$106.37 range, driven by a sharp Q4 deceleration, continued RPO flattening, and sector rotation out of high-multiple AI software. The base case is most likely, and its key assumption is that the Q3 contract-value slowdown proves temporary rather than structural — the $222.25 average target sits at the top of that base range, so even the consensus view implies consolidation rather than a straight-line advance.
On every standard metric Palantir screens as expensive: PS of 94.1x, EV/Sales of 51.6x, EV/EBITDA of 249.5x, price-to-book of 57.0x, and price-to-cash-flow of 197.3x, against a software sector that typically commands 10–20x sales — a roughly 5–9x premium. The trailing PE of 257.6x collapses to a 63.3x forward PE only because consensus EPS of $14.38 assumes earnings roughly quadruple from the current trailing EPS of $0.0039, and the one metric that looks reasonable, a PEG of 1.13, is entirely dependent on that hyper-growth assumption holding. Relative to its own history the stock is not at an all-time extreme — Q3 2026's 194.5x quarterly PS is below the 301.6x of Q4 2025 — but it remains far above the 61.7x of Q4 2023 and 115.4x of Q3 2024. The market is therefore paying a premium that implies sustained 50%+ growth, continued margin expansion, and no demand air pocket; the verdict is fairly valued to modestly overvalued, not a discount.
From a pure risk/reward standpoint the setup is balanced rather than compelling: at $160.38 the stock sits roughly +38.6% below the $222.25 average analyst target but roughly -50% above the $80 low target, a 3.4x spread that signals genuine disagreement among 28 analysts (22 Buy, 9 Hold, 2 Sell). The business quality is not in question — 95.87% revenue growth, 48.76% net margin, $4.054 billion of TTM free cash flow, and debt-to-equity of 0.031 — but 94.1x sales and 257.6x trailing earnings mean you are paying today for earnings that must roughly quadruple to the $14.38 consensus EPS. The biggest downside risk is multiple compression: the stock already fell from $209.05 on October 9 to $154.99 on November 5, and a repricing toward the $106.37 52-week low would cost about -34%. It is a reasonable buy for long-horizon investors who can tolerate a 1.61 beta and a -48.22% max drawdown and who accumulate via dollar-cost averaging, and a poor buy for anyone who needs the current 94x sales multiple to hold through a deceleration.
Palantir is structurally a long-term holding but tactically a poor short-term trade at this price. The growth stage is late-hyper-growth — revenue accelerated from $1.633 billion in Q1 to $2.313 billion in Q3 2026, a roughly 42% sequential expansion — with earnings visibility anchored by a $14.38 consensus EPS and $70.1 billion consensus revenue, which supports multi-year compounding if execution holds. However, the 1.61 beta, the -48.22% max drawdown, and the -17.38% one-month move against the S&P 500's -4.99% mean short-term holders face violent drawdowns with no dividend (payout ratio of 0) to cushion the ride. A concrete minimum holding period of three to five years is appropriate, ideally built through dollar-cost averaging and sized so a -34% to -50% drawdown to the $106.37 52-week low or $80 analyst low is survivable; traders should wait for either a reclaim of $185–$200 to confirm trend repair or a washout toward $106–$120 to improve the entry.